## Beta-lactam Pharmacology in Respiratory Infection ### Clinical Context The patient has community-acquired pneumonia (CAP) caused by penicillin-susceptible *Streptococcus pneumoniae*. Amoxicillin is an appropriate oral agent for this indication in the outpatient or step-down setting. ### Correct Statements (Options 0, 1, 3) **Option 0 — Amoxicillin Pharmacokinetics:** **Key Point:** Amoxicillin is an aminopenicillin (β-lactamase-susceptible) with excellent oral bioavailability (~90%) and good lung tissue penetration. It is the oral agent of choice for respiratory tract infections caused by susceptible organisms. **Option 1 — Time-Dependent Bactericidal Activity:** **High-Yield:** Beta-lactams exhibit **time-dependent killing**. Bactericidal efficacy correlates with the **percentage of the dosing interval during which serum concentrations remain above the MIC** (often denoted as %T>MIC). For optimal efficacy, %T>MIC should exceed 40–50% of the dosing interval. This is in contrast to aminoglycosides and fluoroquinolones, which show concentration-dependent killing. **Mnemonic:** **T>MIC = Time above MIC** — the longer beta-lactams stay above the MIC, the better the kill. **Option 3 — Renal Excretion and Dose Adjustment:** **Clinical Pearl:** Amoxicillin is excreted predominantly as unchanged drug via the kidneys. In severe renal impairment (CrCl <30 mL/min), accumulation occurs, increasing the risk of toxicity (especially neurotoxicity and seizures). Dose reduction or extended dosing intervals are required. ### Incorrect Statement (Option 2 — THE ANSWER) **Warning:** This is a critical clinical trap. While amoxicillin achieves adequate lung tissue penetration for respiratory infections, it does **NOT** achieve sufficient cerebrospinal fluid (CSF) penetration for meningitis, even in the setting of meningeal inflammation. **Why amoxicillin is inadequate for meningitis:** 1. **Poor CSF penetration:** Even with inflamed meninges, amoxicillin CSF levels are subtherapeutic (typically 5–10% of serum levels). 2. **Inadequate dosing:** Standard amoxicillin doses (500 mg–1 g orally) cannot achieve CSF concentrations sufficient to exceed the MIC of *S. pneumoniae*. 3. **Correct agent for pneumococcal meningitis:** High-dose **intravenous ceftriaxone** (2 g IV Q12H) or **cefotaxime** (2 g IV Q4–6H) are the agents of choice. These third-generation cephalosporins achieve CSF concentrations of 10–20% of serum levels, which is sufficient for meningitis. 4. **Alternative:** High-dose intravenous penicillin G (4 million units IV Q4H) can also be used for pneumococcal meningitis, but oral amoxicillin cannot. ### Pharmacokinetic Comparison: Lung vs. CNS Penetration | Agent | Lung Penetration | CSF Penetration (Inflamed Meninges) | Use in CAP | Use in Meningitis | | --- | --- | --- | --- | --- | | Amoxicillin (oral) | ✓ Good | ✗ Poor (<10%) | ✓ Yes | ✗ No | | Ceftriaxone (IV) | ✓ Good | ✓ Adequate (10–20%) | ✓ Yes | ✓ Yes | | Cefotaxime (IV) | ✓ Good | ✓ Adequate (10–20%) | ✓ Yes | ✓ Yes | | Penicillin G (high-dose IV) | ✓ Good | ✓ Adequate (high-dose) | ✓ Yes | ✓ Yes | [cite:Harrison 21e Ch 139; KD Tripathi 8e Ch 52]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.